Tuesday, 17 November 2015

Costing report: menopause diagnosis and management

"This report focuses on the recommendations that are considered to have the greatest resource impact nationally, and therefore need the most additional resources to implement or can potentially generate the biggest savings. They are:

- decrease the number of follicle-stimulating hormone (FSH) tests in women 
- increase use of transdermal hormone replacement therapy (HRT). "

Costing report: menopause diagnosis and management 
Implementing the NICE guideline on menopause (NG23)
NICE
November 2015

Read more here.

No comments:

Post a Comment